R&D’s contribution to the Lundbeck value chain is as innovators, discovering and developing new therapies to treat neurology and psychiatry indications with high unmet medical needs. R&D has a truly global footprint, employing talented colleagues in Denmark, the United States, China, Japan, and Singapore.

In the U.S., you can join a community dedicated to supporting:

• drug discovery (at the Lundbeck La Jolla Research Center in California)
• cell line development (at Lundbeck Seattle BioPharmaceuticals in Bothell, Wash.) 
• Medical Affairs, Pharmacovigilance and Regulatory Affairs efforts (at our U.S. headquarters in Deerfield, Ill.)  

Across the R&D organization, we are united by an ambition to become number one in brain health in the service of patients; a drive to advance a pipeline of innovative therapies; and a shared commitment to teamwork and personal development.